Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve 1. To Consider and Approve the unaudited standalone financial results for the quarter ended 31st December, 2025 along with Limited Review Report of the auditors;2. To Consider and approve the allotment of equity shares issued through preferential allotment basis.3. Any other matter with the permission of chair.